Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoDisk, Inc. is a biotechnology company focused on the commercialization and licensing of Nanodisc technology, a synthetic model membrane system developed by Professor Stephen Sligar at the University of Illinois. The company's platform utilizes membrane scaffold proteins (MSPs) to create soluble, discoidal lipid bilayers that stabilize integral membrane proteins in a native-like environment. This technology is widely used in drug discovery, structural biology, and the development of novel therapeutics and vaccines targeting membrane-bound proteins. NanoDisk provides specialized reagents and licensing opportunities to pharmaceutical and academic partners to facilitate the study of challenging targets such as GPCRs and ion channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoDisk.